Pages that link to "Q38559244"
Jump to navigation
Jump to search
The following pages link to Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy (Q38559244):
Displaying 25 items.
- Urokinase-type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications (Q26865306) (← links)
- Prostate cancer relevant antigens and enzymes for targeted drug delivery (Q27013843) (← links)
- Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches (Q30354223) (← links)
- Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer (Q34082211) (← links)
- Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging. (Q34204249) (← links)
- Epithelial transport of noscapine across cell monolayer and influence of absorption enhancers on in vitro permeation and bioavailability: implications for intestinal absorption (Q35147276) (← links)
- Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles (Q35687164) (← links)
- Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine (Q35891741) (← links)
- The many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single target (Q36997621) (← links)
- Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy (Q36997627) (← links)
- A novel tumor targeting drug carrier for optical imaging and therapy (Q37695404) (← links)
- Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic (Q37895294) (← links)
- Mesoporous silica nanoparticles in biomedical applications (Q37973069) (← links)
- TRAIL and microRNAs in the treatment of prostate cancer: therapeutic potential and role of nanotechnology (Q38137746) (← links)
- Prostate Cancer Stem Cells and Nanotechnology: A Focus on Wnt Signaling (Q38731643) (← links)
- Fluorescent dye labeled iron oxide/silica core/shell nanoparticle as a multimodal imaging probe (Q38989890) (← links)
- GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78. (Q39254849) (← links)
- Magnetic nanoformulations for prostate cancer (Q39319113) (← links)
- Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach (Q39324907) (← links)
- African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression (Q40646076) (← links)
- Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer (Q42364477) (← links)
- Determination of factors controlling the particle size and entrapment efficiency of noscapine in PEG/PLA nanoparticles using artificial neural networks (Q42965329) (← links)
- Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications. (Q54960825) (← links)
- Chemotherapy of Prostate Cancer by Targeted Nanoparticles Trackable by Magnetic Resonance Imaging (Q58690337) (← links)
- Be Active or Not: the Relative Contribution of Active and Passive Tumor Targeting of Nanomaterials (Q89736584) (← links)